Details for New Drug Application (NDA): 208630
✉ Email this page to a colleague
NDA 208630 describes GLEOLAN, which is a drug marketed by Nxdc and is included in one NDA. It is available from two suppliers. Additional details are available on the GLEOLAN profile page.
The generic ingredient in GLEOLAN is aminolevulinic acid hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the aminolevulinic acid hydrochloride profile page.
The generic ingredient in GLEOLAN is aminolevulinic acid hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the aminolevulinic acid hydrochloride profile page.
Summary for 208630
| Tradename: | GLEOLAN |
| Applicant: | Nxdc |
| Ingredient: | aminolevulinic acid hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 208630
| Mechanism of Action | Fluorescence Contrast Activity |
Medical Subject Heading (MeSH) Categories for 208630
Suppliers and Packaging for NDA: 208630
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| GLEOLAN | aminolevulinic acid hydrochloride | FOR SOLUTION;ORAL | 208630 | NDA | Medexus Pharma, Inc. | 59137-231 | 59137-231-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (59137-231-01) / 1 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| GLEOLAN | aminolevulinic acid hydrochloride | FOR SOLUTION;ORAL | 208630 | NDA | NX DEVELOPMENT CORP | 71469-231 | 71469-231-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (71469-231-01) / 1 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SOLUTION;ORAL | Strength | 1.5GM/VIAL | ||||
| Approval Date: | Jun 6, 2017 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
